PharmaVoice

JULY 1, 2025

“If it is a medication that truly matters to patients, how do you ensure those patients have access to the medication?”

Drug Development 130

Drug Development 130

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

Express Pharma

MARCH 31, 2025

Researchers completed phase 1 clinical trials demonstrating safety and tolerance to NEO100 in 2019. This is different from traditional chemotherapy which is usually given orally and intravenously.

Chemotherapy 66

Chemotherapy 66

STAT

APRIL 21, 2025

  Immunovant was spun out of Roivant in 2019 to develop a pipeline of drugs to treat autoimmune disorders. Immunovant CFO Renee Barnett is also leaving, to be replaced by Tiago Girao, currently the CFO of Televant, another Roivant affiliate company.    Continue to STAT+ to read the full story…

Drug Development 197

Drug Development 197

Express Pharma

JUNE 14, 2025

Ganorkar has been heading India Business at Sun Pharma since June 2019. Sun Pharmaceutical Industries announced the appointment of Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business and all functions reporting to him.

99

99

Drug Patent Watch

DECEMBER 18, 2024

A 2019 survey by the World Intellectual Property Organization (WIPO) found that inadequate prior art searches were responsible for 32% of patent application rejections[2]. Sources cited: Tufts Center for the Study of Drug Development, 2021 World Intellectual Property Organization (WIPO), 2019 Source

Drug Development 94

Drug Development Compounding Dosage Pharmaceutical Companies 94

Express Pharma

APRIL 8, 2025

The division also incorporates international subsidiaries and acquisitionsAustria-based virus safety testing provider ViruSure (acquired in 2019), U.S.-based based Bionique Testing Laboratories (2021), and biologics CDMO Bionova Scientific (2022).

Pharmaceutical Manufacturing 76

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Drug Development 76

PharmaVoice

JUNE 23, 2025

The combo therapy topped $10 billion in revenue last year for the first time since its approval in 2019. For example, Vertex Pharmaceutical’s cystic fibrosis medication Trikafta/Kaftrio is “irreplaceable” in the disease, according to PharmCube.

Diabetes 147

Diabetes Packaging Biosimilars 147

Commonwealth Pharmacists Association

JUNE 30, 2025

It was a bold, but modest, step – funded by a small grant, but driven by a big ambition: to expand equitable access to meaningful, high-quality professional development for pharmacists, particularly in historically under-resourced settings.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Diabetes 52

Pharmacy Times

JUNE 27, 2025

November 21, 2019. Effect of acalabrutinib in combination with bendamustine plus rituximab on survival endpoints in older patients with mantle cell lymphoma: insights from the ECHO trial. healthbook TIMES Onco Hema. 2024;22(4):22-29. doi:10.36000/HBT.OH.2024.22.163 ClinicalTrials.gov. Updated February 19, 2025. Accessed May 14, 2025.

Pharmacy Technician 22

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 22

RX Note

DECEMBER 25, 2024

Demystifying Drug Dosing in Renal Dysfunction, 2019 Demystifying Drug Dosing in Renal Dysfunction serves as a quick reference for commonly used medication dosing given varying degrees of renal dysfunction and/or use of renal replacement modalities.

Dosage 40

Dosage Documentation Hospitals 40

Pharmacy Times

JULY 12, 2025

May 9, 2019. Presented at: McKesson ideaShare 2025. Nashville, TN; July 11, 2025. Pharmacist-prescribed birth control reaches new users, saves Oregon $1.6M. News release. Oregon Health and Science University. Accessed July 11, 2025. Arkansas Maternal Mortality Review Committee. Legislative Report. December 2022. Accessed July 11, 2025.

Pharmacy Technician 26

Pharmacy Technician Independent Pharmacies Hospitals Compounding Pharmacies 26

Express Pharma

MARCH 20, 2025

A3 IQVIA analysis and projection based on National Family Health Survey (NFHS-5), India, 2019-20 and Data from Global Observatory (World Obesity)- [link] Rosenstock J, Wysham C, Frias JP, et al. Obesity, sleep apnea, and hypertension. Hypertension. 2003;42(6):1067-1074. doi:10.1161/01.HYP.0000101686.98973.A3 0000101686.98973.A3

Diabetes 101

Diabetes Labelling Communication 101

Pharmacy Joe

DECEMBER 1, 2024

While aspiration was not previously addressed head-on in CAP guidelines, new data prompted the 2019 IDSA CAP guideline authors to include the following question: Question 10: In the Inpatient Setting, Should Patients with Suspected Aspiration Pneumonia Receive Additional Anaerobic Coverage beyond Standard Empiric Treatment for CAP?

Nursing Homes 52

Nursing Homes Inpatient Hospitals 52

Express Pharma

JUNE 20, 2025

Omidria Recall – Altaire Pharmaceuticals, 2019: Altaire voluntarily recalled dozens of ophthalmic and injectable sterile products due to lack of sterility assurance, stemming from critical deficiencies in aseptic technique and environmental monitoring. The incident led to major product recalls and significant regulatory action.

Documentation 66

Documentation Compounding Compounding Pharmacies Pharmaceutical Manufacturing 66

Pharmacy Times

JULY 1, 2025

1,2 Tafamidis in the Treatment of ATTR-CM Initially approved in 2019 3 , tafamidis (Vyndamax; Pfizer) is a selective transthyretin (TTR) kinetic stabilizer that binds to thyroxine-binding sites on TTR tetramers, which prevents dissociation into monomers, or the breakdown into amyloid deposits that damage the heart in ATTR-CM. May 6, 2019.

HIV Treatment and Prevention Agents 44

HIV Treatment and Prevention Agents Pharmacy Technician Insurance Coverage and Processing Specialty Pharmacies 44

Pharmacy Times

JULY 9, 2025

1,2 To better understand this relationship, researchers assessed 4754 patients with CLL/SLL who were treated with either venetoclax and obinutuzumab from April 2016 to August 2022 (n = 2104) or zanubrutinib from November 2019 to August 2023 (n = 2650).

Pharmacy Technician 26

Pharmacy Technician Immunization Immunity Compounding Pharmacies 26

Commonwealth Pharmacists Association

JUNE 6, 2025

Since 2019, we have collaborated with Global Health Partnerships to build strategic pharmacy-led partnerships between UK and African health institutions, fostering intercontinental bidirectional learning between multidisciplinary healthcare teams in aid of strengthening antimicrobial stewardship (AMS) capacity across participating countries.

Communication 52

Communication 52

PharmaVoice

JULY 14, 2025

The drug also isn’t new and was first approved in 2014 before being acquired by Currax in 2019. But Currax has seen more uptake in the last few years thanks to the rising profile of obesity meds, especially among patients who might not be a fit for GLP-1s. “I I [saw] this in the 90s, when the SSRIs first came out,” Hampton said.

Pharmaceutical Companies 130

Pharmaceutical Companies Pharmaceutical Companies 130

Pharmacy Times

JUNE 20, 2025

December 12, 2019. How your oncology peers manage the complexities of care. Oncology Live ®. December 13, 2018. Accessed May 15, 2025. Desimone R. Improve work performance with a focus on employee development. Updated January 19, 2024. Accessed May 15, 2025. LinkedIn Workplace Learning Report 2024. LinkedIn Learning. Accessed May 15, 2025.

Pharmacy Technician 46

Pharmacy Technician Compounding Compounding Pharmacies Biosimilars 46

Pharmacy Times

JUNE 19, 2025

million deaths in 2019, and this is predicted to increase to approximately 23 million annual deaths by 2030. SHOW MORE Diet influences blood pressure, cholesterol levels, and overall heart function. Cardiovascular disease (CVD) is the leading cause of mortality worldwide. A steady increase in CVD-related deaths resulted in approximately 18.6

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Hospitals Diabetes 26

European Pharmaceutical Review

APRIL 8, 2025

International Council for Harmonisation (ICH), 2019. International Council for Harmonisation (ICH), 2012. Q11 Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/ Biological Entities). Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management.

Documentation 52

Documentation Packaging Pharmaceutical Manufacturing 52

The Nontraditional Pharmacist

JULY 1, 2025

So, we would have spoken in 2019. The last time we spoke, biosimilars were this new thing and everyone was trying to figure out what was going to happen regulatory-wise and a lot of other changes since then. So, good talking to you. Matt Paterini (01:21): No, we appreciate the time. And remember, COVID was in there too, right?

Hospitals 52

Hospitals Documentation Packaging Labelling 52

Pharmacy Times

JULY 8, 2025

From 2019 to 2023, the percentage of centers using biosimilars increased from about 38.2% (n = 26) to 88.1% (n = 59). There was a slow uptake of infliximab biosimilar use among the ICN centers. Initially, only 1 center (1.9%) within ICN used an infliximab biosimilar in 2016, and five (8.2%) used an infliximab biosimilar in 2018.

Biosimilars 40

Biosimilars HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies 40

European Pharmaceutical Review

APRIL 10, 2025

Available from: [link] Emerging chemical risks in Europe PFAS European Environment Agency [Internet]. www.eea.europa.eu. Available from: [link] Goldenman G, Fernandes M, Holland M, et al. The cost of inaction. PFAS Restriction under REACH [Internet].

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Packaging Documentation Communication 59

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 71

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 71

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 78

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 78

Beckers Hospital Review

JULY 10, 2025

The findings contrast with a 2019 analysis that found 56% of patients experienced withdrawal symptoms, nearly half which were described as severe, The New York Times reported July 9. The earlier study prompted changes to psychiatric guidelines in the United Kingdom and ignited concerns among patients and providers.

Hospitals 52

Hospitals 52

PharmD Live

JUNE 16, 2025

Health at a glance 2019: OECD indicators. New England Journal of Medicine, 365 (21), 2002–2012. link] Centers for Medicare & Medicaid Services. Medicare star ratings technical notes. link] OECD. OECD Publishing. link] Choudhry, N. Fischer, M. Liberman, J. Schneeweiss, S., Pakes, J., … & Shrank, W.

Hospitals 59

Hospitals Mayo Clinic Specialty Pharmacies Communication 59

Pharmacy Times

JULY 1, 2025

031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). Following 2019 to 2020, use of these agents saw a slight decline and stabilization around 75%. 3 The utilization of HER2 therapies increased from 64.6% in 2013 to 80.9%

Pharmacy Technician 40

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization 40

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 52

Express Pharma

JUNE 25, 2025

Data from the WHO’s Malaria Vaccine Implementation Programme (MVIP) conducted in Ghana, Kenya and Malawi between 2019 and 2023, where over two million children received RTS,S, showed a 13 per cent reduction in all-cause mortality and a 22 per cent reduction in severe malaria hospitalisations among vaccine-eligible children.

Vaccines 66

Vaccines 66

Express Pharma

JULY 14, 2025

References IQVIA analysis and projection based on National Family Health Survey (NFHS-5), India, 2019-20 and Data from Global Observatory (World Obesity) -[link] data.worldobesity.org/country/india-95/#data_economic-impact The post Lilly partners with API to launch a CME for obesity appeared first on Express Pharma.

66

66

Express Pharma

JUNE 30, 2025

In 2019, HPV was linked to an estimated 620,000 cancer cases in women and 70,000 in men. The HPV9 vaccine is a recombinant vaccine designed to protect against nine types of Human Papillomavirus (HPV), including those responsible for cervical, vulvar, vaginal, anal, and oropharyngeal cancers, as well as genital warts.

Vaccines 52

Vaccines Packaging 52

Putting Patients First Blog

JUNE 16, 2025

5 (May 2019): e13876, [link] [6] Jennifer Dickman Portz et al., [link] [5] Jan Walker et al., OpenNotes after 7 Years: Patient Experiences with Ongoing Access to Their Clinicians’ Outpatient Visit Notes,” Journal of Medical Internet Research 21, no. Developer Documentation,” CMS.gov , accessed June 4, 2025, [link] [8] Sahalu B.

Documentation 52

Documentation Communication Immunization Immunity 52

RX Note

MARCH 31, 2025

External Links CPG Management of Acne, 2012 eTG Complete - Information about Acne, 2022 Guidelines of care for the management of acne vulgaris, 2016 Light therapies for acne, 2016 AFP - Acne Vulgaris: Diagnosis and Treatment, 2019 Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007-2017, 2020

Mayo Clinic 52

Mayo Clinic Community Pharmacies 52

Express Pharma

JULY 15, 2025

By the end of 2024, Gerresheimer had already achieved a 28 per cent reduction in emissions compared to the base year 2019. The company plans to lower its energy demand through state-of-the-art production technologies and to source 100 per cent of its electricity from renewable energy by 2030.

66

66